Single-cell RNA-Seq analysis identifies a putative epithelial stem cell population in human primary prostate cells in monolayer and organoid culture conditions.

Tara McCray, Daniel Moline, Bethany Baumann, Donald J Vander Griend, Larisa Nonn
Author Information
  1. Tara McCray: Department of Pathology, University of Illinois at Chicago Chicago 60612, Illinois, USA.
  2. Daniel Moline: Committee on Development, Regenerative, and Stem Cell Biology (DRSB), University of Chicago Chicago 60637, Illinois, USA.
  3. Bethany Baumann: Department of Pathology, University of Illinois at Chicago Chicago 60612, Illinois, USA.
  4. Donald J Vander Griend: Department of Pathology, University of Illinois at Chicago Chicago 60612, Illinois, USA.
  5. Larisa Nonn: Department of Pathology, University of Illinois at Chicago Chicago 60612, Illinois, USA.

Abstract

Human primary prostate epithelial (PrE) cells represent patient-derived models and are traditionally grown as a monolayer in two-dimensional culture. It has been recently demonstrated that expansion of primary cells into three-dimensional prostatic organoids better mimics prostate epithelial glands by recapitulating epithelial differentiation and cell polarity. Here, we sought to identify cell populations present in monolayer PrE cells and organoid culture, grown from the same patient, using single-cell RNA-sequencing. Single-cell RNA-sequencing is a powerful tool to analyze transcriptome profiles of thousands of individual cells simultaneously, creating an in-depth atlas of cell populations within a sample. Organoids consisted of six distinct cell clusters (populations) of intermediate differentiation compared to only three clusters in the monolayer prostate epithelial cells. Integrated analysis of the datasets allowed for direct comparison of the monolayer and organoid samples and identified 10 clusters, including a distinct putative prostate stem cell population that was high in Keratin 13 (), Lymphocyte Antigen 6D (), and Prostate Stem Cell Antigen (). Many of the genes within the clusters were validated through RT-qPCR and immunofluorescence in PrE samples from 5 additional patients. KRT13+ cells were observed in discrete areas of the parent tissue and organoids. Pathway analyses and lack of EdU incorporation corroborated a stem-like phenotype based on the gene expression and quiescent state of the KRT13+ cluster. Other clusters within the samples were similar to epithelial populations reported within patient prostate tissues. In summary, these data show that the epithelial stem population is preserved in PrE cultures, with organoids uniquely expanding intermediate cell types not present in monolayer culture.

Keywords

References

  1. Differentiation. 2001 Oct;68(4-5):270-9 [PMID: 11776479]
  2. Methods. 2001 Dec;25(4):402-8 [PMID: 11846609]
  3. Methods Mol Med. 2003;81:41-57 [PMID: 12725113]
  4. J Cell Biochem. 2004 Jan 1;91(1):185-95 [PMID: 14689590]
  5. J Cell Biochem. 2004 Jan 1;91(1):196-205 [PMID: 14689591]
  6. Clin Sci (Lond). 2005 Jan;108(1):1-11 [PMID: 15384949]
  7. J Urol. 2005 Feb;173(2):342-59 [PMID: 15643172]
  8. J Urol. 2005 Feb;173(2):360-72 [PMID: 15643173]
  9. Eur J Cell Biol. 2005 Mar;84(2-3):341-54 [PMID: 15819412]
  10. Cancer Res. 2006 Sep 1;66(17):8598-607 [PMID: 16951173]
  11. Oncol Rep. 2010 Feb;23(2):465-70 [PMID: 20043108]
  12. Methods Mol Biol. 2013;945:365-82 [PMID: 23097118]
  13. In Vitro Cell Dev Biol. 1986 Feb;22(2):82-90 [PMID: 2419302]
  14. Bioinformatics. 2014 Feb 15;30(4):523-30 [PMID: 24336805]
  15. Nat Biotechnol. 2014 Apr;32(4):381-386 [PMID: 24658644]
  16. Cell. 2014 Sep 25;159(1):163-175 [PMID: 25201529]
  17. Nat Cell Biol. 2014 Oct;16(10):951-61, 1-4 [PMID: 25241035]
  18. Dev Biol. 2015 Apr 1;400(1):94-104 [PMID: 25641695]
  19. Nat Biotechnol. 2015 May;33(5):495-502 [PMID: 25867923]
  20. Cell. 2015 May 21;161(5):1202-1214 [PMID: 26000488]
  21. PLoS One. 2015 Jun 25;10(6):e0130118 [PMID: 26110651]
  22. Stem Cells. 2015 Nov;33(11):3356-67 [PMID: 26220362]
  23. Nat Protoc. 2016 Feb;11(2):347-58 [PMID: 26797458]
  24. Nat Commun. 2016 Feb 29;7:10798 [PMID: 26924072]
  25. Cell. 2016 Jun 16;165(7):1586-1597 [PMID: 27315476]
  26. CA Cancer J Clin. 2017 Jan;67(1):7-30 [PMID: 28055103]
  27. Development. 2017 Apr 15;144(8):1382-1398 [PMID: 28400434]
  28. Stem Cell Res. 2017 Aug;23:1-12 [PMID: 28651114]
  29. Cell Rep. 2017 Aug 15;20(7):1609-1622 [PMID: 28813673]
  30. Asian J Urol. 2017 Jul;4(3):148-151 [PMID: 29264223]
  31. Nat Biotechnol. 2018 Jun;36(5):411-420 [PMID: 29608179]
  32. Nature. 2018 Aug;560(7718):319-324 [PMID: 30069044]
  33. Cell Rep. 2018 Dec 11;25(11):3006-3020.e7 [PMID: 30540935]
  34. Cell Rep. 2018 Dec 18;25(12):3504-3518.e6 [PMID: 30566873]
  35. Cell Rep. 2018 Dec 18;25(12):3530-3542.e5 [PMID: 30566875]
  36. J Vis Exp. 2019 Jan 17;(143):null [PMID: 30735176]
  37. iScience. 2019 Feb 22;12:304-317 [PMID: 30735898]
  38. In Vitro Cell Dev Biol. 1988 Jun;24(6):530-6 [PMID: 3391931]

Grants

  1. T32 GM007183/NIGMS NIH HHS